• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Patterns of antibody response to SARS-CoV-2 among 1.6 million blood donors: Impact of vaccination, United States December 2020 – June 2021

Mary Wilson

Well-known member
Published: 09 October 2021

The Journal of Infectious Diseases, jiab514, https://doi.org/10.1093/infdis/jiab514

Roger Y Dodd, PhD, Edward P Notari, MPH, Jaye P Brodsky, BS, Gregory A Foster, BA, Meng Xu, MPH, Paula Saá, PhD, Susan L Stramer, MS, PhD

Abstract

From December 2020 to June 2021, 1,654,487 blood donors were tested for antibodies to SARS-CoV-2 S1 protein and 1,028,547 (62.17%) were reactive. A rapid increase in prevalence was due to vaccination. Among a subset of 1,567,446 donors, 729,771 (46.56%) reported SARS-CoV-2 vaccination, of whom 633,769 (86.84%) were S1-antibody reactive only, in response to vaccination and 68,269 (9.35%) were reactive to both S1 and nucleocapsid, in response to prior infection; the remainder were not reactive to either antibody. Among the 837,675 (53.44%) donors who did not report vaccination, 210,022 (25.07%) had reactivity to both antibodies and 29,446 (3.52%) to S1 only.

This content is only available as a PDF.
https://watermark.silverchair.com/j...DF-QKAIiGXdhEoWLYuHu3sMobu9SJHXv2tvRke2eUrkqR
 
Back
Top Bottom